HIV-1 T-cell vaccines: evaluating the next step
- 1 February 2008
- journal article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 8 (2) , 82-83
- https://doi.org/10.1016/s1473-3099(07)70266-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239Journal of Virology, 2006
- Cytotoxic T-Lymphocyte Escape Does Not Always Explain the Transient Control of Simian Immunodeficiency Virus SIVmac239 Viremia in Adenovirus-Boosted and DNA-Primed Mamu-A*01-Positive Rhesus MacaquesJournal of Virology, 2005
- Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing GagJournal of Virology, 2005
- Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowNature Medicine, 2004
- HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressorsNature Immunology, 2002
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + LymphocytesScience, 1999
- Effect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1996
- Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIVNature, 1994